Biomarker Discoveries in Gastric Precancerous Lesions
Offered By: Stanford Department of Medicine via YouTube
Course Description
Overview
Explore groundbreaking biomarker discoveries in gastric precancerous lesions in this 37-minute conference talk from the 2022 Gastric Cancer Summit. Presented by Dr. Constanza Camargo from The National Cancer Institute, delve into the Early Detection Research Network's findings on gastric cancer. Examine the roles of pepsinogen, inflammation, and H. pylori serology in early detection. Investigate multiplex studies combining pepsinogen and serology techniques. Uncover insights on genetic susceptibility, microRNAs, and methylation in gastric cancer development. Analyze trends, hypotheses, and key results that shape our understanding of gastric precancerous lesions. Gain valuable knowledge to advance gastric cancer research and early detection strategies.
Syllabus
Introduction
Early Detection Research Network
Gastric Cancer
Pepsinogen
Inflammation
Hpyloliserology
Multiplex studies
Pepsinogen and serology
Genetic susceptibility
MicroRNAs
Methylation
Trends
Hypothesis
Results
Key Concepts
Taught by
Stanford Department of Medicine
Related Courses
El abordaje multidisciplinar de las demenciasUniversidad de Cantabria via MirÃadax Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique Extracellular Vesicles in Health and Disease
University of California, Irvine via Coursera Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
The British Society for Antimicrobial Chemotherapy via FutureLearn